Literature DB >> 16041064

Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells.

E Novo1, F Marra, E Zamara, L Valfrè di Bonzo, A Caligiuri, S Cannito, C Antonaci, S Colombatto, M Pinzani, M Parola.   

Abstract

BACKGROUND AND AIMS: Activated myofibroblast-like cells, originating from hepatic stellate cells (HSC/MFs) or other cellular sources, play a key profibrogenic role in chronic liver diseases (CLDs) that, as suggested by studies in animal models or rat HSC/MFs, may be modulated by reactive oxygen intermediates (ROI). In this study, human HSC/MFs, exposed to different levels of superoxide anion (O(2)(.-)) and, for comparison, hydrogen peroxide (H(2)O(2)), were analysed in terms of cytotoxicity, proliferative response, and migration.
METHODS: Cultured human HSC/MFs were exposed to controlled O(2)(.-) generation by hypoxanthine/xanthine oxidase systems or to a range of H(2)O(2) concentrations. Induction of cell death, proliferation, and migration were investigated using morphology, molecular biology, and biochemical techniques.
RESULTS: Human HSC/MFs were shown to be extremely resistant to induction of cell death by O(2)(.-) and only high rates of O(2)(.-) generation induced either necrotic or apoptotic cell death. Non-cytotoxic low levels of O(2)(.-), able to upregulate procollagen type I expression (but not tissue inhibitor of metalloproteinase 1 and 2), stimulated migration of human HSC/MFs in a Ras/extracellular regulated kinase (ERK) dependent, antioxidant sensitive way, without affecting basal or platelet derived growth factor (PDGF) stimulated cell proliferation. Non-cytotoxic levels of H(2)O(2) did not affect Ras/ERK or proliferative response. A high rate of O(2)(.-) generation or elevated levels of H(2)O(2 )induced cytoskeletal alterations, block in motility, and inhibition of PDGF dependent DNA synthesis.
CONCLUSIONS: Low non-cytotoxic levels of extracellularly generated O(2)(.-) may stimulate selected profibrogenic responses in human HSC/MFs without affecting proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041064      PMCID: PMC1856394          DOI: 10.1136/gut.2005.069633

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  46 in total

Review 1.  NADPH oxidase: an update.

Authors:  B M Babior
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells.

Authors:  A Gentilini; F Marra; P Gentilini; M Pinzani
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

3.  Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 5.  Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.

Authors:  M Pinzani; P Gentilini
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells.

Authors:  N Nieto; S L Friedman; P Greenwel; A I Cederbaum
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

7.  c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells.

Authors:  M Buck; D J Kim; K Houglum; T Hassanein; M Chojkier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-02       Impact factor: 4.052

8.  Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells.

Authors:  P J De Bleser; G Xu; K Rombouts; V Rogiers; A Geerts
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

9.  Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E.

Authors:  F Marra; R DeFranco; C Grappone; M Parola; S Milani; G Leonarduzzi; S Pastacaldi; U O Wenzel; M Pinzani; M U Dianzani; G Laffi; P Gentilini
Journal:  J Investig Med       Date:  1999-01       Impact factor: 2.895

10.  Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice.

Authors:  Olga Teufelhofer; Wolfram Parzefall; Eveline Kainzbauer; Franziska Ferk; Constanze Freiler; Siegfried Knasmüller; Leonilla Elbling; Ronald Thurman; Rolf Schulte-Hermann
Journal:  Carcinogenesis       Date:  2004-10-28       Impact factor: 4.944

View more
  31 in total

1.  Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.

Authors:  Sudjit Luanpitpong; Siera Jo Talbott; Yon Rojanasakul; Ubonthip Nimmannit; Varisa Pongrakhananon; Liying Wang; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  p38-MAPK- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid.

Authors:  Noor Mohamed Jameel; Chinnasamy Thirunavukkarasu; Tong Wu; Simon C Watkins; Scott L Friedman; Chandrashekhar R Gandhi
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

3.  NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.

Authors:  Hasibur Rehman; Venkat K Ramshesh; Tom P Theruvath; Insil Kim; Robert T Currin; Shailendra Giri; John J Lemasters; Zhi Zhong
Journal:  J Pharmacol Exp Ther       Date:  2008-09-18       Impact factor: 4.030

4.  Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.

Authors:  Smitha Antony; Yongzhong Wu; Stephen M Hewitt; Miriam R Anver; Donna Butcher; Guojian Jiang; Jennifer L Meitzler; Han Liu; Agnes Juhasz; Jiamo Lu; Krishnendu K Roy; James H Doroshow
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

Review 5.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

6.  Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression?

Authors:  Giovanni Tarantino; Antonio Gentile; Domenico Capone; Vincenzo Basile; Marianna Tarantino; Matteo-Nicola-Dario Di Minno; Alberto Cuocolo; Paolo Conca
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 7.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Corn peptides protect against thioacetamide-induced hepatic fibrosis in rats.

Authors:  Jie Lv; Zhi-Kui Nie; Jiu-Liang Zhang; Feng-Yan Liu; Zhen-Zhen Wang; Zhi-Li Ma; Hui He
Journal:  J Med Food       Date:  2013-09-24       Impact factor: 2.786

9.  Redox mechanisms in hepatic chronic wound healing and fibrogenesis.

Authors:  Erica Novo; Maurizio Parola
Journal:  Fibrogenesis Tissue Repair       Date:  2008-10-13

Review 10.  Redox control of the cell cycle in health and disease.

Authors:  Ehab H Sarsour; Maneesh G Kumar; Leena Chaudhuri; Amanda L Kalen; Prabhat C Goswami
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.